Keros Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of KROS for the last quarter is 388.00 k USD, and it's 948.65% higher compared to the previous quarter. The net income of Q3 24 is -52.96 M USD.